Top Markets
Coin of the day
Tauriga Sciences, Inc. Tauriga Sciences, Inc.

Tauriga Sciences, Inc.

TAUG
Classement en actions #42808
Tauriga Sciences, Inc. (TAUG) is primarily engaged in the manufacturing and... Tauriga Sciences, Inc. (TAUG) is primarily engaged in the manufacturing and distribution of its cannabidiol (CBD) infused chewing gum, sold under the brand name Tauri-Gum. The company also offers a diverse product portfolio, which includes a line of anti-nausea solutions. Its extensive collection of skincare items features CBD facemasks, daily moisturizers, anti-wrinkle creams (including specialized versions for dream, hand, and foot, often formulated with hemp seed oil), massage and body oils, body revive roll-ons, transdermal patches, and body sprays. Additionally, Tauriga Sciences provides a rainbow deluxe sampler pack, non-GMO CBD dietary supplements, and a variety of CBD-infused scented bath bombs. The firm distributes its merchandise through its e-commerce platform, various distributors, and wholesale channels. Notably, Tauriga Sciences has established a partnership with Aegea Biotechnologies, Inc. to collaborate on the development of a rapid, multiplex COVID-19 (novel coronavirus) diagnostic test. Established in 2001, the company maintains its corporate headquarters in Wappingers Falls, New York.
Prix de l'action
$0.000001
Dernière synchronisation: 2023-08-11
Capitalisation boursière
$56.43
Changement (1 jour)
-90.00%
Changement (1 an)
0.00%
Pays
US
Échange Tauriga Sciences, Inc. (TAUG)

Catégorie

Bénéfices pour Tauriga Sciences, Inc. (TAUG)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Tauriga Sciences, Inc., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Tauriga Sciences, Inc. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes